Results 321 to 330 of about 277,923 (365)

Globulin.

The Journal of physiology, 2007
openaire   +3 more sources

Antithymocyte-globulin/Immune-globulin/Rituximab

Reactions Weekly
openaire   +2 more sources

Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti–T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease–Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation

Journal of Clinical Oncology, 2017
Robert J Soiffer, Haesook T Kim, Joseph P Mcguirk   +2 more
exaly  

Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: a randomised, controlled, open-label, phase 3, multicentre trial

Lancet Oncology, The, 2016
Irwin Walker, Tony Panzarella, Mohamed Elemary   +2 more
exaly  

Globuline

Fresenius' Zeitschrift für analytische Chemie, 1960
openaire   +1 more source

Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial

Lancet Neurology, The, 2008
Vera Bril, Marinos C Dalakas, H-P Hartung   +2 more
exaly  

Intravenous immune globulin suppresses angiogenesis in mice and humans

Signal Transduction and Targeted Therapy, 2016
Valeria Tarallo, Yoshio Hirano, Nagaraj Kerur   +2 more
exaly  

Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome

International Journal of Molecular Sciences, 2020
Xianqin Qu, Richard Donnelly
exaly  

Ganciclovir/cytomegalovirus immune globulin/immune globulin

Reactions Weekly, 2010
openaire   +1 more source

Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial

Lancet Diabetes and Endocrinology,the, 2013
Steven M Willi, Antoinette Moran
exaly